UC Berkeley HHMI
HHMI
UC Berkeley Doudna Research Group UC Berkeley
..: UC Berkeley > DRG > People > Sean Alemi :.. ..: Contact Us | Links | Private | Search | © :..

Sean Alemi

Hepatitis C virus (HCV) infects about 170 million people worldwide. A critical aspect of the virus's ability to infect the host is its efficiency in using the human translation machinery to synthesize its own proteins. The HCV mRNA does this by using an internal ribosomal entry site (IRES) - one of the most conserved regions of the HCV genome - rather than cap dependent initiation, potentially freeing it from normal cellular regulation. In addition to binding the 40S ribosome, the HCV IRES specifically binds to and requires human translation initiation factor eiF3.

Cryo-electron microscopy models suggest that there is a large surface of interaction between the HCV IRES and eIF3, but the details of this interaction are mostly unknown. The IIIabc region of the IRES is thought to be especially important, and is the focus of much of my efforts. By incorporating 4-thio-uridine, a nucleotide that will cross link in the presence of long wave UV light, I aim to create a transcript that can be covalently linked to the eIF3 protein complex. The ultimate goal of these efforts is to clarify which of the 13 subunits of eIF3 the HCV RNA interacts with.

..: Back :..